ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,719, issued on May 26, was assigned to SANOFI (Paris).

"Panel of ER regulated genes for use in monitoring endocrine therapy in breast cancer" was invented by Monsif Bouaboula (Cambridge, Mass.), Hui Cao (Cambridge, Mass.), Joon Sang Lee (Cambridge, Mass.), Vasiliki Pelekanou (Cambridge, Mass.) and Maysoun Shomali (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a panel of ER regulated genes and method for using the panel for monitoring the response of an individual having cancer to treatment with amcenestrant, the method comprising determining a first ER activity score from a sample from the individua...